Adiponectin polymorphisms and non-alcoholic fatty liver disease risk: A meta-analysis

Journal of Gastroenterology and Hepatology (Australia)

Volumn 29, Issue 7, 2014, Pages 1396-1405

  Wang, Jun ^a   Guo, Xu Feng ^a   Yu, Shi Jie ^a   Song, Jia ^a   Zhang, Ji Xiang ^a   Cao, Zhuo ^a   Wang, Jing ^a   Ji, Meng Yao ^a   Dong, Wei Guo ^a  

^a RENMIN HOSPITAL OF WUHAN UNIVERSITY   (China)

Author keywords

Adiponectin; Meta analysis; Non alcoholic fatty liver disease; Polymorphism

Indexed keywords

ADIPONECTIN;

ASIAN; CASE CONTROL STUDY; CAUCASIAN; ETHNICITY; GENETIC ASSOCIATION; GENOTYPE; HUMAN; META ANALYSIS; NONALCOHOLIC FATTY LIVER; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; REVIEW; RISK FACTOR; SENSITIVITY ANALYSIS; SINGLE NUCLEOTIDE POLYMORPHISM; SYSTEMATIC REVIEW; ASIAN CONTINENTAL ANCESTRY GROUP; BIBLIOGRAPHIC DATABASE; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETICS; PROTECTION;

ADIPONECTIN; ASIAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; DATABASES, BIBLIOGRAPHIC; GENETIC PREDISPOSITION TO DISEASE; HUMANS; NON-ALCOHOLIC FATTY LIVER DISEASE; POLYMORPHISM, GENETIC; PROTECTIVE FACTORS; RISK FACTORS;

EID: 84904333289     PISSN: 08159319     EISSN: 14401746     Source Type: Journal    
DOI: 10.1111/jgh.12562     Document Type: Review

References (44)

1. Lazo M, Clark JM. The epidemiology of nonalcoholic fatty liver disease: a global perspective. Semin. Liver Dis. 2008; 28: 339-350.
2. Adams LA, Angulo P, Lindor KD. Nonalcoholic fatty liver disease. CMAJ 2005; 172: 899-905.
3. Mendez-Sanchez N, Arrese M, Zamora-Valdes D, Uribe M. Current concepts in the pathogenesis of nonalcoholic fatty liver disease. Liver Int. 2007; 27: 423-433.
4. Angulo P. Nonalcoholic fatty liver disease. N. Engl. J. Med. 2002; 346: 1221-1231.
5. Cnop M, Havel PJ, Utzschneider KM etal. Relationship of adiponectin to body fat distribution, insulin sensitivity and plasma lipoproteins: evidence for independent roles of age and sex. Diabetologia 2003; 4: 459-469.
6. Yang WS, Chuang LM. Human genetics of adiponectin in the metabolic syndrome. J. Mol. Med. (Berl.) 2006; 84: 112-121.
7. Pagano C, Soardo G, Esposito W etal. Plasma adiponectin is decreased in nonalcoholic fatty liver disease. Eur. J. Endocrinol. 2005; 152: 113-118.
8. Louthan MV, Barve S, McClain CJ, Joshi-Barve S. Decreased serum adiponectin: an early event in pediatric nonalcoholic fatty liver disease. J. Pediatr. 2005; 147: 835-838.
9. Gong LQ, Li L, Zhao XG etal. Association of single nucleotide polymorphisms of the adiponectin gene and plasma levels of adiponectin with risk of nonalcoholic fatty liver disease. Xinjiang Yike Daxue Xuebao 2013; 36: 860-864.
10. Gupta AC, Misra R, Sakhuja P, Singh Y, Basir SF, Sarin SK. Association of adiponectin gene functional polymorphisms (-11377C/G and +45T/G) with nonalcoholic fatty liver disease. Gene 2012; 496: 63-67.
11. Hashemi M, Hanafi Bojd H, Eskandari Nasab E etal. Association of adiponectin rs1501299 and rs266729 gene polymorphisms with nonalcoholic fatty liver disease. Hepat. Mon. 2013; 13: e9527.
12. Huang CM, Li YY, Zhou YJ, Nie YQ, Du YL. Correlation between adiponectin gene polymorphisms and susceptibility of non-alcoholic fatty liver disease. Guangzhou Yixueyuan Xuebao 2010; 38: 1-5.
13. Musso G, Gambino R, De Michieli F, Durazzo M, Pagano G, Cassader M. Adiponectin gene polymorphisms modulate acute adiponectin response to dietary fat: possible pathogenetic role in NASH. Hepatology 2008; 47: 1167-1177.
14. Shi SL, Nie YQ, Li YY, Zhou YJ, Du YL. Association of T45G polymorphism in exon 2 of adiponectin gene with nonalcoholic fatty liver disease. Guangzhou Yixueyuan Xuebao 2005; 33: 1-3.
15. Tokushige K, Hashimoto E, Noto H etal. Influence of adiponectin gene polymorphisms in Japanese patients with non-alcoholic fatty liver disease. J. Gastroenterol. 2009; 44: 976-982.
16. Wang ZL, Xia B, Shrestha U etal. Correlation between adiponectin polymorphisms and non-alcoholic fatty liver disease with or without metabolic syndrome in Chinese population. J. Endocrinol. Invest. 2008; 31: 1086-1091.
17. Wong VW, Wong GL, Tsang SW etal. Genetic polymorphisms of adiponectin and tumor necrosis factor-alpha and nonalcoholic fatty liver disease in Chinese people. J. Gastroenterol. Hepatol. 2008; 23: 914-921.
18. Zhou YJ, Li YY, Nie YQ etal. Influence of polygenetic polymorphisms on the susceptibility to non-alcoholic fatty liver disease of Chinese people. J. Gastroenterol. Hepatol. 2010; 25: 772-777.
19. Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur. J. Epidemiol. 2010; 25: 603-605.
20. Lau J, Ioannidis JP, Schmid CH. Quantitative synthesis in systematic reviews. Ann. Intern. Med. 1997; 127: 820-826.
21. Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J. Natl Cancer Inst. 1959; 22: 719-748.
22. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control. Clin. Trials 1986; 7: 177-188.
23. Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics 1994; 50: 1088-1101.
24. Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997; 315: 629-634.
25. Neuschwander-Tetri B, Caldwell S. Nonalcoholic steatohepatitis: summary of an AASLD single topic conference. Hepatology 2003; 37: 1202-1219.
26. Obika M, Noguchi H. Diagnosis and evaluation of nonalcoholic fatty liver disease. Exp. Diabetes Res. 2012; 2012: 145754.
27. Tarantino G, Colao A, Capone D etal. Circulating levels of cytochrome C, gammaglutamyl transferase, triglycerides and unconjugated bilirubin in overweight/obese patients with non-alcoholic fatty liver disease. J. Biol. Regul. Homeost. Agents 2011; 25: 47-56.
28. Wilfred de Alwis NM, Day CP. Genes and nonalcoholic fatty liver disease. Curr. Diab. Rep. 2008; 8: 156-163.
29. Di Rosa M, Malaguarnera L. Genetic variants in candidate genes influencing NAFLD progression. J. Mol. Med. (Berl.) 2012; 90: 105-118.
30. Wang JK, Feng ZW, Li YC, Li QY, Tao XY. Association of tumor necrosis factor-α gene promoter polymorphism at sites -308 and -238 with non-alcoholic fatty liver disease: a meta-analysis. J. Gastroenterol. Hepatol. 2012; 27: 670-676.
31. Finelli C, Tarantino G. What is the role of adiponectin in obesity related non-alcoholic fatty liver disease? World J. Gastroenterol. 2013; 19: 802-812.
32. Gatselis NK, Ntaios G, Makaritsis K, Dalekos GN. Adiponectin: a key playmaker adipocytokine in non-alcoholic fatty liver disease. Clin. Exp. Med. 2013. doi: 10.1007/s10238-012-0227-0
33. Bugianesi E, Pagotto U, Manini R etal. Plasma adiponectin in nonalcoholic fatty liver is related to hepatic insulin resistance and hepatic fat content, not to liver disease severity. J. Clin. Endocrinol. Metab. 2005; 90: 3498-3504.
34. Wong VW, Hui AY, Tsang SW etal. Metabolic and adipokine profile of Chinese patients with nonalcoholic fatty liver disease. Clin. Gastroenterol. Hepatol. 2006; 4: 1154-1161.
35. Polyzos SA, Toulis KA, Goulis DG, Zavos C, Kountouras J. Serum total adiponectin in nonalcoholic fatty liver disease: a systematic review and meta-analysis. Metabolism 2011; 60: 313-326.
36. Fan HJ, Wen ZF, Xu BL etal. Three adiponectin rs1501299G/T, rs822395A/C, and rs822396A/G polymorphisms and risk of cancer development: a meta-analysis. Tumour Biol. 2013; 34: 769-778.
37. Ye CC, Wang J, Tan SY, Zhang J, Li M, Sun P. Meta-analysis of adiponectin polymorphisms and colorectal cancer risk. Int. J. Med. Sci. 2013; 10: 1113-1120.
38. Jing C, Xueyao H, Linong J. Meta-analysis of association studies between five candidate genes and type 2 diabetes in Chinese Han population. Endocrine 2012; 42: 307-320.
39. Jia H, Yu L, Guo X, Gao W, Jiang Z. Associations of adiponectin gene polymorphisms with polycystic ovary syndrome: a meta-analysis. Endocrine 2012; 42: 299-306.
40. Yu Z, Han S, Cao X, Zhu C, Wang X, Guo X. Genetic polymorphisms in adipokine genes and the risk of obesity: a systematic review and meta-analysis. Obesity (Silver Spring) 2012; 20: 396-406.
41. Zhang H, Mo X, Hao Y, Gu D. Association between polymorphisms in the adiponectin gene and cardiovascular disease: a meta-analysis. BMC Med. Genet. 2012; 13: 40.
42. Xi B, He D, Wang Q, Xue J, Liu M, Li J. Common polymorphisms (rs2241766 and rs1501299) in the ADIPOQ gene are not associated with hypertension susceptibility among the Chinese. Mol. Biol. Rep. 2012; 39: 8771-8775.
43. Laumen H, Saningong AD, Heid IM etal. Functional characterization of promoter variants of the adiponectin gene complemented by epidemiological data. Diabetes 2009; 58: 984-991.
44. Boccia S, De Feo E, Gallì P, Gianfagna F, Amore R, Ricciardi G. A systematic review evaluating the methodological aspects of meta-analyses of genetic association studies in cancer research. Eur. J. Epidemiol. 2010; 25: 765-775.